Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males
Open Access
- 29 November 2016
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 6 (11) , e961
Abstract
Preclinical research demonstrates that cannabinoids have differing effects in adolescent and adult animals. Whether these findings translate to humans has not yet been investigated. Here we believe we conducted the first study to compare the acute effects of cannabis in human adolescent (n=20; 16–17 years old) and adult (n=20; 24–28 years old) male cannabis users, in a placebo-controlled, double-blind cross-over design. After inhaling vaporized active or placebo cannabis, participants completed tasks assessing spatial working memory, episodic memory and response inhibition, alongside measures of blood pressure and heart rate, psychotomimetic symptoms and subjective drug effects (for example, ‘stoned’, ‘want to have cannabis’). Results showed that on active cannabis, adolescents felt less stoned and reported fewer psychotomimetic symptoms than adults. Further, adults but not adolescents were more anxious and less alert during the active cannabis session (both pre- and post-drug administration). Following cannabis, cognitive impairment (reaction time on spatial working memory and prose recall following a delay) was greater in adults than adolescents. By contrast, cannabis impaired response inhibition accuracy in adolescents but not in adults. Moreover, following drug administration, the adolescents did not show satiety; instead they wanted more cannabis regardless of whether they had taken active or placebo cannabis, while the opposite was seen for adults. These contrasting profiles of adolescent resilience (blunted subjective, memory, physiological and psychotomimetic effects) and vulnerability (lack of satiety, impaired inhibitory processes) show some degree of translation from preclinical findings, and may contribute to escalated cannabis use by human adolescents.Keywords
This publication has 89 references indexed in Scilit:
- Persistent cannabis users show neuropsychological decline from childhood to midlifeProceedings of the National Academy of Sciences of the United States of America, 2012
- Delay- and Dose-Dependent Effects of Δ9-Tetrahydrocannabinol Administration on Spatial and Object Working Memory Tasks in Adolescent Rhesus MonkeysNeuropsychopharmacology, 2012
- Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokersMolecular Psychiatry, 2011
- The synthetic cannabinoid WIN 55212-2 differentially modulates thigmotaxis but not spatial learning in adolescent and adult animalsNeuroscience Letters, 2011
- Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinenceAddictive Behaviors, 2010
- Energy expenditure and agingAgeing Research Reviews, 2010
- Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effectsEuropean Neuropsychopharmacology, 2008
- Abstinent adolescent marijuana users show altered fMRI response during spatial working memoryPsychiatry Research: Neuroimaging, 2008
- Functional MRI of inhibitory processing in abstinent adolescent marijuana usersPsychopharmacology, 2007
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991